Compare AMLX & NAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMLX | NAK |
|---|---|---|
| Founded | 2014 | 1983 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 922.7M |
| IPO Year | 2022 | 2002 |
| Metric | AMLX | NAK |
|---|---|---|
| Price | $14.24 | $2.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $17.43 | $2.50 |
| AVG Volume (30 Days) | 1.4M | ★ 7.2M |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.60 | $0.45 |
| 52 Week High | $16.96 | $2.98 |
| Indicator | AMLX | NAK |
|---|---|---|
| Relative Strength Index (RSI) | 52.32 | 63.17 |
| Support Level | $13.50 | $1.78 |
| Resistance Level | $15.24 | $1.92 |
| Average True Range (ATR) | 0.97 | 0.14 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 56.84 | 91.13 |
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.
Northern Dynasty Minerals Ltd is a mineral exploration company. It has a single operating segment of acquisition, exploration, and development of mineral properties. Its core asset is the Pebble Project located in Alaska, USA. The Pebble project is seeking to develop a deposit of copper, gold, molybdenum, and silver into a modern mining operation.